Ansari Djafari, A. et al. 2023. Intravesical Gemcitabine versus Intravesical Bacillus Calmette-Guerin for the Treatment of Intermediate-Risk Non-Muscle Invasive Bladder Cancer: A Randomized Controlled Trial. Urology Journal. 20, 02 (Feb. 2023), 123–128. DOI:https://doi.org/10.22037/uj.v20i02.7194.